返回
BrainAurora Medical Technology Limited（06681.HK）價格
06681.HK 股價走勢圖
BRAINAURORA-B (06681.HK)
BrainAurora Medical Technology Limited
HK$6.41
-0.15%
$0
盤中： Jan 20, 15:27:39 HKT
暫無資料Earnings FAQ
06681.HK 最近的每股盈餘與預期相比如何？
BrainAurora Medical Technology Limited 06681.HK 上一季度的收入表現如何？
BrainAurora Medical Technology Limited 的收入預期是多少？
BrainAurora Medical Technology Limited 的盈利品質評分是多少？
BrainAurora Medical Technology Limited 何時發布財報？
BrainAurora Medical Technology Limited 的預期收益是多少？
BrainAurora Medical Technology Limited 是否超出收益預期？
關鍵數據
前收市價
$6.42
開盤價
$6.42
當日範圍
$6.37 - $6.62
52週區間
$3.13 - $17.79
交易量
24.3M
平均成交量
17.5M
每股盈餘 (TTM)
-0.18
股息收益率
--
市值
$8.1B
什麼是 BRAINAURORA-B？
Brainaurora Medical Technology Ltd. engages in research and development of medical-grade cognitive impairment digital therapeutics (DTx) products. The company is headquartered in Shaoxing, Zhejiang and currently employs 174 full-time employees. The company went IPO on 2025-01-08. The firm's main business is engaged in offering the system integral software solutions to hospitals which enables the hospitals to offer assessment and intervention to their cognitive impairment patients. The firm is also engaged in offering research projects services as well as technical and operational support services. The firm's main product is Brain Function Information Management Platform Software System, which enables clinical assessment and interventions for various types of cognitive impairment induced by vascular diseases, neurodegenerative diseases, psychological disorders and child development deficiencies, among other types of cognitive impairments. The firm mainly conducts its business in the domestic market.